Microsules

Microsules Argentina is a prominent Argentine pharmaceutical company founded in 1969, specializing in the development, manufacture, and commercialization of high-quality human and veterinary medicines. The company operates state-of-the-art manufacturing facilities, including a dedicated oncology plant in Garín, Buenos Aires, which produces complex injectables, liquids, and lyophilized products under strict GMP standards. Microsules Argentina's diverse portfolio spans oncology, oncohematology, HIV/AIDS treatments, cardiovascular therapies, and general medicine. Additionally, through its veterinary division and subsidiaries like Laboratorios Microsules Uruguay, the company is a major player in animal health, recently launching innovative products like the resveratrol-based pet supplement line, Juvenia. With a strong export profile, Microsules distributes its products to numerous countries across Latin America, Asia, Africa, and the Middle East.